Pricing

Log inSign up

ReCode Therapeutics

1 follower

‌

ReCode Therapeutics is an integrated genetic medicines company developing targeted, disease-modifying therapies for patients with life-limiting respiratory diseases.

Industries

Biotechnology

Headquarters

Menlo Park, United States

Employees

51-200

Links

Org chart

Shehnaaz Suliman
CEO
Collapse
David J Lockhart
President & Chief Scientific Officer
Vladimir G. Kharitonov
SVP, CMC
Erica V. Jefferson
SVP, Corporate Affairs
Daniel Siegwart
Co-Founder
Heather Clark
Svp, CF Franchise Lead
SM
Sakya Mohapatra
Senior Director, Formulation and Process Development
Teri Keffer
Head Of People
Ariel Kantor
Vice President, Business Development & Platform Strategy
MB
Max Barker
General Counsel
AL
Alyce Arnick Lichaa
Senior Director Finance, Head of FP&A

Board & advisors

EH
Ed Hurwitz
Director
Helen S. Kim
Director
PT
Peter Thompson
Director
ON
Oleg Nodelman
Director
RA
Rana Al-Hallaq
Director
TM
Trisha Millican
Director
AC
Alan Colowick
Director
DS
Daniel J. Siegwart
Chair, Scientific Advisory Board
Eric Olson
Scientific Advisor
Justin Hanes
Scientific Advisor
Carrolee Barlow
Scientific Advisor
Rafael Amado
Scientific Advisor
Elliott Sigal
Scientific Advisor

Teams

+27

Research and Development

31 people · 0 jobs

EH
ON
PT
+9

Directors Team

13 people · 0 jobs

Leadership Team

3 people · 0 jobs

AL
MP
MR
+1

Business Development & Strategy

5 people · 0 jobs

+2

Human Resources and Operations

6 people · 0 jobs

Research and Development

4 people · 0 jobs

Offices

Similar companies

Sutro Biopharma

3 followers

Active Motif

3 followers

Dyno Therapeutics

4 followers

Janux Therapeutics

1 follower

Eikon Therapeutics

3 followers

Gilead Sciences

157 followers

Regeneron

124 followers

Illumina

78 followers

Agilent Technologies

78 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

44 followers

Explore companies